Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Grignard like Coupling and Stereoselective Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109553609A reveals a safer Canagliflozin synthesis route. Achieve high purity without alpha-isomers and reduce operational costs in pharmaceutical intermediate manufacturing.